UH's Sugar Land campus has a new innovation hub focused on machine learning in the energy industry. Photo via UH.edu

The University of Houston at Sugar Land is now home to an innovative lab that will work to find new ways to use artificial intelligence in the oilfield.

Dubbed the Artificial Intelligence Industry Incubator and Digital Oilfield Lab at the University of Houston, the facility will allow faculty, students, and energy professionals to develop technologies and solutions to increase efficiency and boost oil field safety through machine learning, according to a release from UH.

The lab opened in late 2020 and is part of the College of Technology's Advanced Technology and Innovation Laboratory. It represents a partnership with the UH College of Technology and the AI Innovation Consortium based in Louisville, Kentucky.

The consortium also includes Pennsylvania State University, the University of Louisville, Louisiana State University, and a number of corporations.

According to the release from UH, several companies have already agreed to work with the lab on projects that will find ways to use AI for predictive analytics, visual inspection, and health and safety measures.

"This incubator program emphasizes the need to build projects grounded in clear business value, with technologically rich and hands-on initiatives, and an engaging industry/academia partnership," Konrad Konarski, chair and director of operations at AIIC, says in a statement. "This allows us to focus on the most relevant AI technologies that have immediate impact and value to the oil and gas industry."

Too, the lab aims to provide students with valuable experiences that they can likely leverage into a job upon graduation.

"The laboratory and incubator will allow our students to contribute to the various applied research and proof of concept work currently underway and in the future," David Crawley, professor of practice in the College of Technology, says in a statement. "This includes working with the AIIC's commercial partners to create opportunities to move their incubator experience and advanced academic background into jobs at participating operations."

The university has also made headway in recent months using machine learning to better the search for "super hard" materials, such as diamonds. It also launched a new drug discovery institute in November.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston femtech co. debuts new lactation and wellness pods

mom pod

Houston-based femtech company Work&, previously known as Work&Mother, has introduced new products in recent months aimed at supporting working mothers and the overall health of all employees.

The company's new Lactation Pod and Hybrid Pod serve as dual-use lactation and wellness spaces to meet employer demand, the company shared in a news release. The compact pods offer flexible design options that can serve permanent offices and nearly all commercial spaces.

They feature a fully compliant lactation station while also offering wellness functionalities that can support meditation, mental health, telehealth and prayer. In line with Work&'s other spaces, the pods utilize the Work& scheduling platform, which prioritizes lactation bookings to help employers comply with the PUMP Act.

“This isn’t about perks,” Jules Lairson, Work& co-founder and COO, said in the release. “It’s about meeting people where they are—with dignity and intentional design. That includes the mother returning to work, the employee managing anxiety, and everyone in between.”

According to the company, several Fortune 500 companies are already using the pods, and Work& has plans to grow the products' reach.

Earlier this year, Work& introduced its first employee wellness space at MetroNational’s Memorial City Plazas, representing Work&'s shift to offer an array of holistic health and wellness solutions for landlords and tenants.

The company, founded in 2017 by Lairson and CEO Abbey Donnell, was initially focused on outfitting commercial buildings with lactation accommodations for working parents. While Work& still offers these services through its Work&Mother branch, the addition of its Work&Wellbeing arm allowed the company to also address the broader wellness needs of all employees.

The company rebranded as Work& earlier this year.

Rice biotech studio secures investment from Modi Ventures, adds founder to board

fresh funding

RBL LLC, which supports commercialization for ventures formed at the Rice University Biotech Launch Pad, has secured an investment from Houston-based Modi Ventures.

Additionally, RBL announced that it has named Sahir Ali, founder and general partner of Modi Ventures, to its board of directors.

Modi Ventures invests in biotech companies that are working to advance diagnostics, engineered therapeutics and AI-driven drug discovery. The firm has $134 million under management after closing an oversubscribed round this summer.

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. William McKeon, president and CEO of the TMC, previously called the launch of RBL a “critical step forward” for Houston’s life sciences ecosystem.

“RBL is dedicated to building companies focused on pioneering and intelligent bioelectronic therapeutics,” Ali said in a LinkedIn post. “This partnership strengthens the Houston biotech ecosystem and accelerates the transition of groundbreaking lab discoveries into impactful therapies.”

Ali will join board members like managing partner Paul Wotton, Rice bioengineering professor Omid Veiseh, scientist and partner at KdT Ventures Rima Chakrabarti, Rice alum John Jaggers, CEO of Arbor Biotechnologies Devyn Smith, and veteran executive in the life sciences sector James Watson.

Ali has led transformative work and built companies across AI, cloud computing and precision medicine. Ali also serves on the board of directors of the Drug Information Association, which helps to collaborate in drug, device and diagnostics developments.

“This investment by Modi Ventures will be instrumental to RBL’s growth as it reinforces confidence in our venture creation model and accelerates our ability to develop successful biotech startups,” Wotton said in the announcement. "Sahir’s addition to the board will also amplify this collaboration with Modi. His strategic counsel and deep understanding of field-defining technologies will be invaluable as we continue to grow and deliver on our mission.”